Covid-19: World’s first human trials given green light in UKon February 17, 2021 at 10:22 am

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Healthy, young volunteers are being recruited for the approved study, which will start shortly.

Doctor with volunteer having vaccine

image copyrightGetty Images

Healthy, young volunteers will be infected with coronavirus to test vaccines and treatments in the world’s first Covid-19 “human challenge” study, which will take place in the UK.

The study, which has received ethics approval, will start in the next few weeks and recruit 90 people aged 18-30.

They will be exposed to the virus in a safe and controlled environment while medics monitor their health.

The UK has given doses of a Covid vaccine to more than 15 million people.

Human challenge studies have played a vital role in pushing the development of treatments for a number of diseases, including malaria, typhoid, cholera and flu.

The trials will help scientists work out the smallest amount of coronavirus needed to cause infection, and how the body’s immune system reacts to it.

This will give doctors a better understanding of Covid-19, the disease caused by the virus, which will feed into the development of vaccines and treatments.

The Human Challenge study is being delivered by a partnership between the UK government’s Vaccines Taskforce, Imperial College London, the Royal Free London NHS Foundation Trust and the company hVIVO, which has pioneered viral human challenge models.

Clive Dix, interim chair of the Vaccines Taskforce, said: “We have secured a number of safe and effective vaccines for the UK, but it is essential that we continue to develop new vaccines and treatments for Covid-19.

“We expect these studies to offer unique insights into how the virus works and help us understand which promising vaccines offer the best chance of preventing the infection.”

Initially, the study will use the virus that has been circulating in the UK since the pandemic began in March, which is of low risk to healthy adults, to deliberately infect volunteers.

In time, a small numbers of volunteers are likely to be given an approved vaccine and then exposed to the virus, helping scientists to find out the most effective ones.

Volunteers are being asked to come forward and take part in the study. They will be compensated for their time, the government says.

Chief investigator Dr Chris Chiu, from Imperial College London, said: “We are asking for volunteers aged between 18 and 30 to join this research endeavour and help us to understand how the virus infects people and how it passes so successfully between us.”

Dr Chiu said the eventual aim was to find out which vaccines and treatments work best in beating the disease.

The BBC is not responsible for the content of external sites.

- Advertisement -




Woods wins $8m for generating media interest – despite playing once all yearon March 2, 2022 at 4:53 pm

Tiger Woods wins $8m (£5.99m) for generating more media interest than any other golfer in 2021 - even though he played just one tournament...

Queen’s Christmas message pays tribute to ‘beloved’ Philipon December 25, 2021 at 4:21 pm

The Queen remembers her late husband and how his "mischievous, inquiring twinkle" stayed "bright" to the end.This video can not be playedTo play this...

The Papers: ‘A new Iron Curtain’ and ‘100m for the Royals?’on June 29, 2022 at 10:50 pm

More Nato troops in eastern Europe and a £15m rise in the Royal Family's grant feature in the papers.More Nato troops in eastern Europe...

Afghan crisis: Chaos as Europeans scramble to evacuate Kabulon August 18, 2021 at 12:31 pm

Several countries rush to fly people out, as the Dutch government is criticised for reacting slowly.image sourceGetty ImagesChaotic conditions have been reported outside Kabul...

Sabre Corporation Offers Travel Options To Its Employees

Sabre Corporation Offers Travel Options To Its EmployeesThe headquarters of Sabre Corporation is located in the San Francisco Bay Area and the location...